Literature DB >> 11861845

Herpes simplex virus selectively induces expression of the CC chemokine RANTES/CCL5 in macrophages through a mechanism dependent on PKR and ICP0.

Jesper Melchjorsen1, Finn S Pedersen, Søren C Mogensen, Søren R Paludan.   

Abstract

Recruitment of leukocytes is essential for eventual control of virus infections. Macrophages represent a leukocyte population involved in the first line of defense against many infections, including herpes simplex virus (HSV) infection. Through presentation of antigens to T cells and production of cytokines and chemokines, macrophages also constitute an important link between the innate and adaptive immune systems. Here, we have investigated the chemokine expression profile of macrophages after HSV infection and the virus-cell interactions involved. By reverse transcription-PCR and cDNA arrays, we found that HSV type 1 (HSV-1) and HSV-2 induced expression of the CC chemokine RANTES/CCL5 in murine macrophage cell lines and peritoneal cells. The CXC chemokine BCA-1/CXCL13 was also induced in peritoneal cells. Twenty-six other chemokines tested were not affected. Accumulation of RANTES mRNA was detectable after 5 h of infection, was sensitive to UV irradiation of the virus, and was preceded by accumulation of viral immediate-early mRNA and proteins. The viral components responsible for initiation of RANTES expression were examined with virus mutants and RAW 264.7 macrophage-like cells expressing a dominant negative mutant of the double-stranded-RNA-activated protein kinase (PKR). The PKR mutant cell line displayed reduced constitutive and HSV-inducible RANTES expression compared to the control cell line. HSV-1 mutants deficient in genes encoding the immediate-early proteins ICP4, ICP22, and ICP27 remained fully capable of inducing RANTES expression in macrophages. By contrast, the ability of an ICP0-deficient HSV-1 mutant to induce RANTES expression was compromised. Thus, HSV selectively induces expression of RANTES in macrophages through a mechanism dependent on cellular PKR and viral ICP0.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11861845      PMCID: PMC135968          DOI: 10.1128/jvi.76.6.2780-2788.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption.

Authors:  S Müller; A Dejean
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

2.  Absence of macrophage inflammatory protein-1alpha prevents the development of blinding herpes stromal keratitis.

Authors:  T M Tumpey; H Cheng; D N Cook; O Smithies; J E Oakes; R N Lausch
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

3.  Expression of Mig (monokine induced by interferon-gamma) is important in T lymphocyte recruitment and host defense following viral infection of the central nervous system.

Authors:  M T Liu; D Armstrong; T A Hamilton; T E Lane
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

4.  ICP22 and the UL13 protein kinase are both required for herpes simplex virus-induced modification of the large subunit of RNA polymerase II.

Authors:  M C Long; V Leong; P A Schaffer; C A Spencer; S A Rice
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

5.  Modulation of immunity against herpes simplex virus infection via mucosal genetic transfer of plasmid DNA encoding chemokines.

Authors:  S K Eo; S Lee; S Chun; B T Rouse
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

6.  DNA vaccines encoding interleukin-8 and RANTES enhance antigen-specific Th1-type CD4(+) T-cell-mediated protective immunity against herpes simplex virus type 2 in vivo.

Authors:  J Sin; J J Kim; C Pachuk; C Satishchandran; D B Weiner
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

7.  Activation-dependent modulation of B lymphocyte migration to chemokines.

Authors:  M Brandes; D F Legler; B Spoerri; P Schaerli; B Moser
Journal:  Int Immunol       Date:  2000-09       Impact factor: 4.823

8.  The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease.

Authors:  M T Liu; B P Chen; P Oertel; M J Buchmeier; D Armstrong; T A Hamilton; T E Lane
Journal:  J Immunol       Date:  2000-09-01       Impact factor: 5.422

9.  Herpes simplex virus type 2 induces secretion of IL-12 by macrophages through a mechanism involving NF-kappaB.

Authors:  Lene Malmgaard; Søren R Paludan; Søren C Mogensen; Svend Ellermann-Eriksen
Journal:  J Gen Virol       Date:  2000-12       Impact factor: 3.891

10.  The chemokine macrophage-inflammatory protein-1 alpha and its receptor CCR1 control pulmonary inflammation and antiviral host defense in paramyxovirus infection.

Authors:  J B Domachowske; C A Bonville; J L Gao; P M Murphy; A J Easton; H F Rosenberg
Journal:  J Immunol       Date:  2000-09-01       Impact factor: 5.422

View more
  16 in total

Review 1.  Herpesviral infection and Toll-like receptor 2.

Authors:  Ming-sheng Cai; Mei-li Li; Chun-fu Zheng
Journal:  Protein Cell       Date:  2012-08-04       Impact factor: 14.870

Review 2.  Oncolytic herpes simplex virus interactions with the host immune system.

Authors:  Dipongkor Saha; Hiroaki Wakimoto; Samuel D Rabkin
Journal:  Curr Opin Virol       Date:  2016-08-03       Impact factor: 7.090

Review 3.  Herpes simplex virus and the chemokines that mediate the inflammation.

Authors:  D J J Carr; L Tomanek
Journal:  Curr Top Microbiol Immunol       Date:  2006       Impact factor: 4.291

4.  Herpes simplex virus type 1 ICP27-dependent activation of NF-kappaB.

Authors:  Danna Hargett; Stephen Rice; Steven L Bachenheimer
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

5.  The immune response to herpes simplex virus encephalitis in mice is modulated by dietary vitamin E.

Authors:  Patricia A Sheridan; Melinda A Beck
Journal:  J Nutr       Date:  2008-01       Impact factor: 4.798

6.  Suppression of proinflammatory cytokine expression by herpes simplex virus type 1.

Authors:  Trine H Mogensen; Jesper Melchjorsen; Lene Malmgaard; Antonella Casola; Søren R Paludan
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

7.  Latent herpesvirus infection in human trigeminal ganglia causes chronic immune response.

Authors:  Diethilde Theil; Tobias Derfuss; Igor Paripovic; Simone Herberger; Edgar Meinl; Olaf Schueler; Michael Strupp; Viktor Arbusow; Thomas Brandt
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

8.  Induction of interleukin-6 in human retinal epithelial cells by an attenuated Herpes simplex virus vector requires viral replication and NFkappaB activation.

Authors:  Suping Cai; Curtis R Brandt
Journal:  Exp Eye Res       Date:  2007-12-03       Impact factor: 3.467

Review 9.  Prophylactic vaccine strategies and the potential of therapeutic vaccines against herpes simplex virus.

Authors:  Michael W Ferenczy
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

Review 10.  Learning from the messengers: innate sensing of viruses and cytokine regulation of immunity - clues for treatments and vaccines.

Authors:  Jesper Melchjorsen
Journal:  Viruses       Date:  2013-01-31       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.